{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:59:00Z","timestamp":1790049540651,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00117-020-00779-y","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T22:22:09Z","timestamp":1605824529000},"page":"1153-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Was passiert eigentlich\u00a0\u2026 in der Hybridbildgebung?","What actually happens\u00a0\u2026 in hybrid imaging?"],"prefix":"10.1007","volume":"60","author":[{"given":"C.","family":"Rischpler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"issue":"3","key":"779_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/JCI100131","volume":"4","author":"HL Blumgart","year":"1927","unstructured":"Blumgart\u00a0HL, Weiss\u00a0S (1927) Studies on the velocity of blood flow. J\u00a0Clin Invest 4(3):399\u2013425","journal-title":"J Clin Invest"},{"key":"779_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0002-8703(64)90271-6","volume":"68","author":"JR Carrea","year":"1964","unstructured":"Carrea\u00a0JR, Gleason\u00a0G, Shaw\u00a0J, Krontz\u00a0B (1964) The direct diagnosis of myocardinal infarction by photoscanning after administration of CESIUM-131. Am Heart\u00a0J 68:627\u2013636","journal-title":"Am Heart J"},{"issue":"6","key":"779_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/a-1023-3960","volume":"58","author":"O Lindner","year":"2019","unstructured":"Lindner\u00a0O, Burchert\u00a0W, Buechel\u00a0R, Sch\u00e4fer\u00a0WM, Arbeitsgemeinschaft \u201eKardiovaskul\u00e4re Nuklearmedizin\u201c der Deutschen Gesellschaft f\u00fcr Nuklearmedizin, AG20 \u201eNuklearkardiologische Diagnostik\u201c der Deutschen Gesellschaft f\u00fcr Kardiologie. (2019) Myocardial perfusion SPECT 2018 in Germany: results of the 8th survey. Nuklearmedizin 58(6):425\u2013433","journal-title":"Nuklearmedizin"},{"issue":"3","key":"779_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti\u00a0J, Wijns\u00a0W, Saraste\u00a0A, Capodanno\u00a0D, Barbato\u00a0E, Funck-Brentano\u00a0C et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart\u00a0J 41(3):407\u2013477","journal-title":"Eur Heart J"},{"issue":"23","key":"779_CR5","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehp304","volume":"30","author":"O Gaemperli","year":"2009","unstructured":"Gaemperli\u00a0O, Husmann\u00a0L, Schepis\u00a0T, Koepfli\u00a0P, Valenta\u00a0I, Jenni\u00a0W et al (2009) Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a\u00a0potential gatekeeper for coronary revascularization? Eur Heart\u00a0J 30(23):2921\u20132929","journal-title":"Eur Heart J"},{"issue":"9","key":"779_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/ehjci\/jew038","volume":"17","author":"R Liga","year":"2016","unstructured":"Liga\u00a0R, Vontobel\u00a0J, Rovai\u00a0D, Marinelli\u00a0M, Caselli\u00a0C, Pietila\u00a0M et al (2016) Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging 17(9):951\u2013960","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"779_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcmg.2017.05.020","volume":"11","author":"A Rizvi","year":"2018","unstructured":"Rizvi\u00a0A, Han\u00a0D, Danad\u00a0I, Hartaigh \u00d3B, Lee\u00a0JH, Gransar\u00a0H et al (2018) Diagnostic performance of hybrid cardiac imaging methods for assessment of obstructive coronary artery disease compared with stand-alone coronary computed Tomography Angiography: a meta-analysis. JACC Cardiovasc Imaging 11(4):589\u2013599","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"779_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/eurheartj\/ehr047","volume":"32","author":"AP Pazhenkottil","year":"2011","unstructured":"Pazhenkottil\u00a0AP, Nkoulou\u00a0RN, Ghadri\u00a0J\u2011R, Herzog\u00a0BA, Buechel\u00a0RR, K\u00fcest\u00a0SM et al (2011) Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart\u00a0J 32(12):1465\u20131471","journal-title":"Eur Heart J"},{"issue":"4","key":"779_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ehjci\/jes224","volume":"14","author":"JR Ghadri","year":"2013","unstructured":"Ghadri\u00a0JR, Fiechter\u00a0M, Fuchs\u00a0TA, Scherrer\u00a0A, Stehli\u00a0J, Gebhard\u00a0C et\u00a0al (2013) Registry for the Evaluation of the PROgnostic value of a\u00a0novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT). Eur Heart J Cardiovasc Imaging 14(4):374\u2013380","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"779_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04877-w","author":"T Vitadello","year":"2020","unstructured":"Vitadello T, Kunze KP, Nekolla SG, Langwieser N, Bradaric C, Weis F et\u00a0al (2020) Hybrid PET\/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-04877-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"779_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jamainternmed.2013.8203","volume":"173","author":"T Lalani","year":"2013","unstructured":"Lalani\u00a0T, Chu\u00a0VH, Park\u00a0LP, Cecchi\u00a0E, Corey\u00a0GR, Durante-Mangoni\u00a0E et al (2013) In-hospital and 1\u2011year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 173(16):1495\u20131504","journal-title":"JAMA Intern Med"},{"issue":"23","key":"779_CR12","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","volume":"61","author":"L Saby","year":"2013","unstructured":"Saby\u00a0L, Laas\u00a0O, Habib\u00a0G, Cammilleri\u00a0S, Mancini\u00a0J, Tessonnier\u00a0L et al (2013) Positron emission tomography\/computed tomography for\u00a0diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a\u00a0novel major criterion. J\u00a0Am Coll Cardiol 61(23):2374\u20132382","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"779_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.115.015316","volume":"132","author":"MN Pizzi","year":"2015","unstructured":"Pizzi\u00a0MN, Roque\u00a0A, Fern\u00e1ndez-Hidalgo\u00a0N, Cu\u00e9llar-Calabria\u00a0H, Ferreira-Gonz\u00e1lez\u00a0I, Gonz\u00e0lez-Alujas\u00a0MT et al (2015) Improving the diagnosis of infective endocarditis in prosthetic valves and Intracardiac devices with 18F-fluordeoxyglucose positron emission tomography\/computed Tomography Angiography. Circulation 132(12):1113\u20131126","journal-title":"Circulation"},{"issue":"44","key":"779_CR14","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib\u00a0G, Lancellotti\u00a0P, Antunes\u00a0MJ, Bongiorni\u00a0MG, Casalta\u00a0J\u2011P, Del Zotti\u00a0F et al (2015) 2015 ESC guidelines for the management of infective endocarditisthe task force for the management of infective endocarditis of the European Society of Cardiology (ESC)endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart\u00a0J 36(44):3075\u20133128","journal-title":"Eur Heart J"},{"issue":"1","key":"779_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12350-015-0325-y","volume":"24","author":"SP Salom\u00e4ki","year":"2017","unstructured":"Salom\u00e4ki\u00a0SP, Saraste\u00a0A, Kemppainen\u00a0J, Bax\u00a0JJ, Knuuti\u00a0J, Nuutila\u00a0P et al (2017) 18F-FDG positron emission tomography\/computed tomography in infective endocarditis. J\u00a0Nucl Cardiol 24(1):195\u2013206","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"779_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1253\/jcj.44.249","volume":"44","author":"M Sekiguchi","year":"1980","unstructured":"Sekiguchi\u00a0M, Numao\u00a0Y, Imai\u00a0M, Furuie\u00a0T, Mikami\u00a0R (1980) Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a\u00a0study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ\u00a0J 44(4):249\u2013263","journal-title":"Jpn Circ J"},{"issue":"7","key":"779_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie\u00a0DH, Sauer\u00a0WH, Bogun\u00a0F, Cooper\u00a0JM, Culver\u00a0DA, Duvernoy\u00a0CS et\u00a0al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11(7):1305\u20131323","journal-title":"Heart Rhythm"},{"issue":"1","key":"779_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"RHJA Slart","year":"2018","unstructured":"Slart\u00a0RHJA, Glaudemans\u00a0AWJM, Lancellotti\u00a0P, Hyafil\u00a0F, Blankstein\u00a0R, Schwartz\u00a0RG et\u00a0al (2018) A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J\u00a0Nucl Cardiol 25(1):298\u2013319","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"779_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","volume":"63","author":"R Blankstein","year":"2014","unstructured":"Blankstein\u00a0R, Osborne\u00a0M, Naya\u00a0M, Waller\u00a0A, Kim\u00a0CK, Murthy\u00a0VL et\u00a0al (2014) Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J\u00a0Am Coll Cardiol 63(4):329\u2013336","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"779_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/eurheartj\/eht335","volume":"35","author":"S Schneider","year":"2014","unstructured":"Schneider\u00a0S, Batrice\u00a0A, Rischpler\u00a0C, Eiber\u00a0M, Ibrahim\u00a0T, Nekolla\u00a0SG (2014) Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment. Eur Heart\u00a0J 35(5):312","journal-title":"Eur Heart J"},{"issue":"1","key":"779_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","volume":"11","author":"MR Dweck","year":"2018","unstructured":"Dweck\u00a0MR, Abgral\u00a0R, Trivieri\u00a0MG, Robson\u00a0PM, Karakatsanis\u00a0N, Mani\u00a0V et\u00a0al (2018) Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active\u00a0cardiac Sarcoidosis. JACC Cardiovasc Imaging 11(1):94\u2013107","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"779_CR22","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita\u00a0T, Okada\u00a0DR, Veillet-Chowdhury\u00a0M, Bravo\u00a0PE, Mullins\u00a0E, Hulten\u00a0E et al (2018) Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac Sarcoidosis. Circ Cardiovasc Imaging 11(1):e7030","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"779_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41824-017-0014-y","volume":"1","author":"R Slart","year":"2017","unstructured":"Slart\u00a0R, Koopmans\u00a0KP, Van\u00a0PG, Kramer\u00a0H, Groen\u00a0HJM, Gan\u00a0CT et\u00a0al (2017) Somatostatin receptor based hybrid imaging in sarcoidosis. Eur J Hybrid Imaging 1(1):7\u20137","journal-title":"Eur J Hybrid Imaging"},{"issue":"17","key":"779_CR24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich\u00a0MG, Sechtem\u00a0U, Schulz-Menger\u00a0J, Holmvang\u00a0G, Alakija\u00a0P, Cooper\u00a0LT et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J\u00a0Am Coll Cardiol 53(17):1475\u20131487","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"779_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12350-016-0616-y","volume":"25","author":"F Nensa","year":"2018","unstructured":"Nensa\u00a0F, Kloth\u00a0J, Tezgah\u00a0E, Poeppel\u00a0TD, Heusch\u00a0P, Goebel\u00a0J et al (2018) Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET\/MRI. J\u00a0Nucl Cardiol 25(3):785\u2013794","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"779_CR26","first-page":"709","volume":"7","author":"RM Witteles","year":"2019","unstructured":"Witteles\u00a0RM, Bokhari\u00a0S, Damy\u00a0T, Elliott\u00a0PM, Falk\u00a0RH, Fine\u00a0NM et\u00a0al (2019) Screening for transthyretin amyloid cardiomyopathy in everyday practice. J\u00a0Am Coll Cardiol 7(8):709\u2013716","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"779_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer\u00a0MS, Schwartz\u00a0JH, Gundapaneni\u00a0B, Elliott\u00a0PM, Merlini\u00a0G, Waddington-Cruz\u00a0M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N\u00a0Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"issue":"24","key":"779_CR28","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore\u00a0JD, Maurer\u00a0MS, Falk\u00a0RH, Merlini\u00a0G, Damy\u00a0T, Dispenzieri\u00a0A et\u00a0al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u20132412","journal-title":"Circulation"},{"issue":"9","key":"779_CR29","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala\u00a0S, Vangala\u00a0D, Semer\u00a0J, Strader\u00a0C, Bruyere\u00a0JR, Di Carli\u00a0MF et\u00a0al (2014) Imaging cardiac amyloidosis: a\u00a0pilot study using 18F\u2011florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging 41(9):1652\u20131662","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"779_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.05.031","author":"D Genovesi","year":"2020","unstructured":"Genovesi D, Vergaro G, Giorgetti A, Marzullo P, Scipioni M, Santarelli MF et al (2020) 18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and\u00a0mimicking conditions. JACC Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2020.05.031","journal-title":"JACC Cardiovasc Imaging"},{"key":"779_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02363-2","author":"M Papathanasiou","year":"2020","unstructured":"Papathanasiou\u00a0M, Kessler\u00a0L, Carpinteiro\u00a0A, Hagenacker\u00a0T, Nensa\u00a0F, Umutlu\u00a0L et al (2020) 18F-flutemetamol positron emission tomography in cardiac amyloidosis. J\u00a0Nucl Cardiol. https:\/\/doi.org\/10.1007\/s12350-020-02363-2","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"779_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","volume":"8","author":"L Baratto","year":"2018","unstructured":"Baratto\u00a0L, Park\u00a0SY, Hatami\u00a0N, Gulaka\u00a0P, Vasanawala\u00a0S, Yohannan\u00a0TK et al (2018) 18F-florbetaben whole-body PET\/MRI for evaluation of systemic amyloid deposition. EJNMMI Res 8(1):66","journal-title":"EJNMMI Res"},{"issue":"1","key":"779_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","volume":"27","author":"YJ Kim","year":"2020","unstructured":"Kim YJ, Ha S, Kim Y\u2011I (2020) Cardiac amyloidosis imaging with amyloid positron emission tomography: a systematic review and meta-analysis. J\u00a0Nucl Cardiol 27(1):123\u2013132. https:\/\/doi.org\/10.1007\/s12350-018-1365-x","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"3","key":"779_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","volume":"4","author":"C Humeres","year":"2019","unstructured":"Humeres\u00a0C, Frangogiannis\u00a0NG (2019) Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl Sci 4(3):449\u2013467","journal-title":"JACC Basic Transl Sci"},{"issue":"18","key":"779_CR35","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa\u00a0P, Old\u00a0LJ, Rettig\u00a0WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a\u00a0potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A 87(18):7235\u20137239","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"779_CR36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner\u00a0T, Loktev\u00a0A, Altmann\u00a0A, Giesel\u00a0F, Kratochwil\u00a0C, Debus\u00a0J et al (2018) Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J\u00a0Nucl Med 59(9):1415\u20131422","journal-title":"J Nucl Med"},{"key":"779_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz736","author":"M Totzeck","year":"2019","unstructured":"Totzeck\u00a0M, Siebermair\u00a0J, Rassaf\u00a0T, Rischpler\u00a0C (2019) Cardiac fibroblast activation detected by positron emission tomography\/computed tomography as a\u00a0possible sign of cardiotoxicity. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehz736","journal-title":"Eur Heart J"},{"key":"779_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02307-w","author":"J Siebermair","year":"2020","unstructured":"Siebermair\u00a0J, K\u00f6hler\u00a0MI, Kupusovic\u00a0J, Nekolla\u00a0SG, Kessler\u00a0L, Ferdinandus\u00a0J et al (2020) Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a\u00a0potential novel biomarker of cardiac injury\/remodeling. J\u00a0Nucl Cardiol. https:\/\/doi.org\/10.1007\/s12350-020-02307-w","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"779_CR39","doi-asserted-by":"publisher","first-page":"e010628","DOI":"10.1161\/CIRCIMAGING.120.010628","volume":"13","author":"MB Heckmann","year":"2020","unstructured":"Heckmann\u00a0MB, Reinhardt\u00a0F, Finke\u00a0D, Katus\u00a0HA, Haberkorn\u00a0U, Leuschner\u00a0F et\u00a0al (2020) Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease. Circ Cardiovasc Imaging 13(9):e10628","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"779_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cpet.2016.05.006","volume":"11","author":"C Rischpler","year":"2016","unstructured":"Rischpler\u00a0C, Nekolla\u00a0SG (2016) PET\/MR imaging in heart disease. PET Clin 11(4):465\u2013477. https:\/\/doi.org\/10.1016\/j.cpet.2016.05.006","journal-title":"PET Clin"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-020-00779-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T15:15:39Z","timestamp":1607008539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-020-00779-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s00117-020-00779-y","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"19 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Rischpler, T.\u00a0Schlosser, L.\u00a0Umutlu, T.\u00a0Rassaf und B.J.\u00a0Krause geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}